Kawsar R Talaat

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. pmc Filarial/human immunodeficiency virus coinfection in urban southern India
    Kawsar R Talaat
    Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Trop Med Hyg 79:558-60. 2008
  2. pmc A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
    Vaccine 27:3744-53. 2009
  3. doi request reprint A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults
    Kawsar R Talaat
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    J Infect Dis 202:1327-37. 2010
  4. pmc An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
    Vaccine 29:3144-8. 2011
  5. pmc An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Influenza Other Respi Viruses 7:66-73. 2013
  6. doi request reprint Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender
    Surender Khurana
    Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    J Infect Dis 205:610-20. 2012

Detail Information

Publications6

  1. pmc Filarial/human immunodeficiency virus coinfection in urban southern India
    Kawsar R Talaat
    Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Trop Med Hyg 79:558-60. 2008
    ..bancrofti infections among HIV-positive persons was 5-9.5%, and there were no quantitative differences in circulating filarial antigen levels between HIV-positive and HIV-negative filarial-infected patients...
  2. pmc A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
    Vaccine 27:3744-53. 2009
    ..Live attenuated influenza vaccines (LAIVs) are being developed and tested against a variety of influenza viruses with pandemic potential. We describe the results of an open-label Phase I trial of a live attenuated H7N3 virus vaccine...
  3. doi request reprint A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults
    Kawsar R Talaat
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
    J Infect Dis 202:1327-37. 2010
    ..When the novel H1N1 influenza A strain appeared in April of 2009, development of novel H1N1 vaccines became a public health priority...
  4. pmc An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
    Vaccine 29:3144-8. 2011
    ..We describe the results of an open label Phase I trial of a live attenuated H6N1 influenza virus vaccine (ClinicalTrials.gov Identifier: NCT00734175)...
  5. pmc An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
    Kawsar R Talaat
    Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Influenza Other Respi Viruses 7:66-73. 2013
    ..Live attenuated influenza vaccines (LAIV) against a variety of strains of pandemic potential are being developed and tested. We describe the results of an open-label phase I trial of a live attenuated H2N2 virus vaccine...
  6. doi request reprint Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender
    Surender Khurana
    Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    J Infect Dis 205:610-20. 2012
    ..The H1N1 2009 influenza (H1N1pdm09) pandemic had unexpected features, including lower morbidity and mortality in elderly populations...